CRA is a proud exhibiting sponsor of this event.
Cecile Matthews is presenting during the session titled “What is the relationship between price and prevalence in non-oncology rare disease?”
Greg Bell is presenting during the session titled “Simplifying patient tracking,” showcasing RD Navigator.
For more information on this event, click here.
Beyond the single asset: The rise of combination and synergistic innovation in neurology drug development
Introduction Historically, drug development within the neurology space has been characterized by the search for individual therapies that can arrest complex...